Loading compare…
6 funds hold both · as on Aug 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 6 mutual funds hold active equity positions in both Larsen & Toubro and Symbiotec Pharmalab. The scheme with the highest combined exposure is (Edelweiss MF), which holds a 4.52% stake in Larsen & Toubro and a 1.39% stake in Symbiotec Pharmalab, amounting to a combined conviction weight of 5.91%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Larsen wt. | Symbiotec wt. | Combined |
|---|---|---|---|
| Edelweiss MF · Equity (Diversified) | 4.52% | 1.39% | |
| Tata Flexi Cap FundTata MF · Flexi Cap | 2.66% | 0.43% | |
| Tata ELSS - Tax Saver FundTata MF · ELSS (Tax Saver) | 3.00% | 0.02% | |
| Tata Dividend Yield FundTata MF · Dividend Yield | 2.89% | 0.02% | |
| IB29-Groww Multicap FundGroww MF · Multi Cap | 1.53% | 0.47% | |
| ICICI Prudential Equity Savings FundICICI Pru MF · Hybrid | 1.80% | 0.03% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on Aug 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.